These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 18627296)

  • 1. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinases as hormones: targets and mechanisms for proteolytic signaling.
    Hansen KK; Oikonomopoulou K; Baruch A; Ramachandran R; Beck P; Diamandis EP; Hollenberg MD
    Biol Chem; 2008 Aug; 389(8):971-82. PubMed ID: 18979623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.
    Oikonomopoulou K; Diamandis EP; Hollenberg MD
    Biol Chem; 2010 Apr; 391(4):299-310. PubMed ID: 20180639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more.
    Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Diamandis EP; Hollenberg MD
    Biol Chem; 2006 Jun; 387(6):677-85. PubMed ID: 16800728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.
    Hansen KK; Oikonomopoulou K; Li Y; Hollenberg MD
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):377-92. PubMed ID: 17952408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation.
    Russell FA; McDougall JJ
    Inflamm Res; 2009 Mar; 58(3):119-26. PubMed ID: 19184346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.
    Hansen KK; Saifeddine M; Hollenberg MD
    Immunology; 2004 Jun; 112(2):183-90. PubMed ID: 15147561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease activated receptors in cardiovascular function and disease.
    Barnes JA; Singh S; Gomes AV
    Mol Cell Biochem; 2004 Aug; 263(1-2):227-39. PubMed ID: 15524183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
    Ramachandran R; Hollenberg MD
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptors: contribution to physiology and disease.
    Ossovskaya VS; Bunnett NW
    Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation signalling following tissue injury: focus on the role of factor Xa.
    Krupiczojc MA; Scotton CJ; Chambers RC
    Int J Biochem Cell Biol; 2008; 40(6-7):1228-37. PubMed ID: 18420447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.
    Arora P; Ricks TK; Trejo J
    J Cell Sci; 2007 Mar; 120(Pt 6):921-8. PubMed ID: 17344429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptors: novel central role in modulation of gastric functions.
    Browning KN
    Neurogastroenterol Motil; 2010 Apr; 22(4):361-5. PubMed ID: 20377791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological actions of protease activated receptors (PARs).
    Pandya NM; Jain SM; Santani DD
    Pharmazie; 2007 Mar; 62(3):163-9. PubMed ID: 17416190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more.
    Hollenberg MD
    J Pharmacol Sci; 2005 Jan; 97(1):8-13. PubMed ID: 15665444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptors.
    Macfarlane SR; Seatter MJ; Kanke T; Hunter GD; Plevin R
    Pharmacol Rev; 2001 Jun; 53(2):245-82. PubMed ID: 11356985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.
    Rohatgi T; Sedehizade F; Reymann KG; Reiser G
    Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptors, apoptosis and tumor growth.
    Borensztajn KS; Spek CA
    Pathophysiol Haemost Thromb; 2008; 36(3-4):137-47. PubMed ID: 19176987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection.
    Luo W; Wang Y; Reiser G
    Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.